Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report
- 137 Downloads
We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m2 and cisplatin, total of 175 mg/m2), cetuximab (initial dose of 400 mg/m2 with subsequent weekly doses of 250 mg/m2 intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.
KeywordsIntra-arterial chemoradiotherapy Hyperthermia Cetuximab N3 cervical lymph node metastasis Oral cancer
Compliance with ethical standards
Conflict of interest
Kaname Sakuma, Toshiyuki Koizumi, Kenji Mitsudo, Jun Ueda, Yuichiro Hayashi, Toshinori Iwai, Makoto Hirota, Mitomu Kioi, Haruka Yoshii, Hisashi Kaizu, Masaharu Hata, Akira Tanaka and Iwai Tohnai declare that they have no conflict of interest.
Human rights statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Informed consent was obtained from the patient for being included in the study. The patient provided permission for his photographs to be published.
- 5.Hattori T, Hirano T, Toyoda S, Nakagawa T, Yamaguchi N, Sakakura Y. Superselective continuous intra-arterial infusion therapy via superficial temporal artery for head and neck tumors. Nihon Igaku Hoshasen Gakkai Zasshi. 1985;45:1056–8. (articleJapanese).Google Scholar
- 6.Fuwa N, Ito Y, Matsumoto A, Kamata M, Kodaira T, Furutani K, et al. A combination therapy of continuous superselective intra-arterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study Cancer. 2000;89:2099–105.Google Scholar
- 8.Mitsudo K, Shigetomi T, Fujimoto Y, Nishiguchi H, Yamamoto N, Furue H, et al. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. Int J Radiat Oncol Bio Phys. 2011;79:1428–35.CrossRefGoogle Scholar
- 12.Mitsudo K, Koizumi T, lida M, Iwai T, Oguri S, Yamamoto N, et al. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases. Int J Radiat Oncol Biol Phys. 2012;83:e639–e45.CrossRefGoogle Scholar
- 14.Huilgol NG. A retrospective analysis of patients with head and neck cancer treated with radiation, hyperthermia, and cetuximab: a brief report of outcome. J Cancer Res Ther. 2016;12:1164–6.Google Scholar